Avax Technologies (Avax Technologies) FCF Margin % : -463.00% (As of Sep. 2008)

View and export this data going back to . Start your Free Trial

What is Avax Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avax Technologies's Free Cash Flow for the three months ended in Sep. 2008 was $-0.93 Mil. Avax Technologies's Revenue for the three months ended in Sep. 2008 was $0.20 Mil. Therefore, Avax Technologies's FCF Margin % for the quarter that ended in Sep. 2008 was -463.00%.

As of today, Avax Technologies's current FCF Yield % is 0.00%.

The historical rank and industry rank for Avax Technologies's FCF Margin % or its related term are showing as below:

AVXT' s FCF Margin % Range Over the Past 10 Years
Min: -981.2 Med: 0 Max: 0
Current: -981.2

AVXT's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -139.2 vs AVXT: -981.20

Avax Technologies FCF Margin % Historical Data

The historical data trend for Avax Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies FCF Margin % Chart

Avax Technologies Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

FCF Margin %

Get a 7-Day Free Trial

-397.74

-165.41

-246.43

-562.45

-787.52

Avax Technologies Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
FCF Margin %	Get a 7-Day Free Trial															-1,265.63	-555.66	-2,227.50	-1,912.50	-463.00

Competitive Comparison of Avax Technologies's FCF Margin %

For the Biotechnology subindustry, Avax Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avax Technologies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avax Technologies's FCF Margin % falls into.

Avax Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avax Technologies's FCF Margin for the fiscal year that ended in Dec. 2007 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2007 )	/	Revenue (A: Dec. 2007 )
	=	-4.859	/	0.617
	=	-787.52 %

Avax Technologies's FCF Margin for the quarter that ended in Sep. 2008 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2008 )	/	Revenue (Q: Sep. 2008 )
	=	-0.926	/	0.2
	=	-463.00 %

Avax Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Avax Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avax Technologies (Avax Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210

Website

http://www.avax-tech.com

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

Executives

Carl Spana	director	PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A	director	ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines